Evidence map›Paper›PMID 41968341›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2026

CytoBatchFlagR: A Comprehensive Framework to Objectively Assess High-Parameter Cytometry Data for Batch Effects.

Shruti Eswar, Zachary T Koenig, Amanda R Tursi, José Cobeña-Reyes, Tamara Tilburgs, Sandra Andorf

Abstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Shruti EswarDepartment of Pharmacology, Physiology & Neurobiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Zachary T KoenigUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Amanda R TursiDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
José Cobeña-ReyesDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Tamara TilburgsDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Sandra AndorfDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0002-3093-2568

Funding

Tissue Repository CoreP30AR070549 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Leah Claire Kottyan · 2016 to 2026
$7.7M
The role of HLA-C in chronic chorioamnionitisR01HD116852 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI Tamara Tilburgs · 2025 to 2026
$1.2M
ZE5 Analytical CytometerS10OD025045 · OD · CINCINNATI CHILDRENS HOSP MED CTR · PI THORNTON, SHERRY L · 2018 to 2018
$359k
Burroughs Wellcome Fund Next Gen Pregnancy Award NGP10115Cincinnati Children's Research FoundationMarch of Dimes Prematurity Research Center Ohio CollaborativeNIAMS NIH HHS P30 AR070549NICHD NIH HHS R01 HD116852NIH HHS P30AR070549NIH HHS R01HD116852NIH HHS S10 OD025045NIH HHS S10OD025045
6 · The paper itself

Abstract

Rapid advancements in mass and flow cytometry technologies have allowed researchers to generate and analyze high-dimensional single cell datasets, often utilizing upwards of 40 protein markers. Such high-parameter cytometry is increasingly used in longitudinal immunological studies, but technical variations across experimental batch runs can confound biological signals. To mitigate the impact on downstream analyses, many studies include reference control samples in every run, and several approaches exist to adjust for batch effects. However, tools that objectively identify problematic batches and markers present within a dataset are limited. We introduce CytoBatchFlagR, a comprehensive and interpretable tool designed to flag batch-related problems at the marker and cell cluster level based on robust statistical evaluations. Batch and marker variations are assessed based on median signal intensities of negative and positive cell populations and positive cell frequencies, along with Earth Mover's Distance (EMD) of signal intensity distributions. Additionally, CytoBatchFlagR identifies cell type specific batch problems via unsupervised clustering. The tool is suitable for mass and flow cytometry datasets where it objectively detects distinct types of batch issues. We developed and tested CytoBatchFlagR using three cytometry datasets to demonstrate its utility and performance. We also demonstrated CytoBatchFlagR's effectiveness in assessing datasets that include or lack reference controls. CytoBatchFlagR improves quality control by enabling objective identification of technical variations that may impact downstream analysis in high-parameter cytometry data. The tool uses a series of complementary metrics to identify potential batch-related problems at the marker and cell population level and presents the results through interpretable visualizations. This allows users to make informed decisions about whether to apply batch correction or exclude specific batches or markers from downstream analyses. CytoBatchFlagR is freely available as R scripts, with documentation and a tutorial to help users get started.

Indexed as

Flow CytometrySingle-Cell AnalysisSoftwareBiomarkersCluster AnalysisClustering AlgorithmsHumansBiomarkersbatch effectsbioinformaticsflow cytometryhigh‐parameterimmunologymass cytometryquality controlsingle‐cell

Identifiers

PMID41968341
PMCPMC13470994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.